Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing enlarged prostate in primary care.

M J Naslund1, F J Costa, M M Miner

  • 1Division of Urology, University of Maryland School of Medicine, Baltimore, MD, USA. mnaslund@smail.umaryland.edu

International Journal of Clinical Practice
|November 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?

Andrology·2015
Same author

Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.

International journal of clinical practice·2011
Same author

Stopwatch-assessed duration of erection: a new measure of the efficacy of erectile dysfunction treatments.

International journal of impotence research·2010
Same author

Biology and natural history of prostate cancer and the role of chemoprevention.

International journal of clinical practice·2010
Same author

Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to lessen cardiovascular risk and all-cause mortality?

International journal of clinical practice·2010
Same author

STEP: simplified treatment of the enlarged prostate.

International journal of clinical practice·2009

Benign prostatic hyperplasia (BPH), or enlarged prostate, requires timely medical management for disease progression and negative outcomes. This review covers evaluating lower urinary tract symptoms and optimizing treatment choices for enlarged prostate.

Area of Science:

  • Urology
  • Primary Care Medicine

Background:

  • Benign prostatic hyperplasia (BPH), or enlarged prostate, is a common condition in aging men.
  • Disease progression in BPH is linked to negative health outcomes.
  • Medical management offers potential for both treating the underlying condition and alleviating symptoms.

Purpose of the Study:

  • To review the evaluation of men presenting with lower urinary tract symptoms (LUTS).
  • To examine challenges associated with the medical treatment of BPH.
  • To suggest strategies for selecting appropriate BPH treatments based on individual patient needs.

Main Methods:

  • Literature review of recent advancements in BPH assessment and treatment.
  • Analysis of evidence regarding disease progression and its consequences.

Related Experiment Videos

  • Synthesis of current approaches to managing lower urinary tract symptoms.

    • Main Results:

    • Accumulated evidence supports the progressive nature of BPH.
    • A clear association exists between BPH progression and adverse health outcomes.
    • Medical management strategies are increasingly recognized for their efficacy.

    Conclusions:

    • Early and effective management of BPH is crucial for preventing disease progression and negative outcomes.
    • Primary care plays a vital role in the long-term preventive care of men with BPH.
    • Tailoring treatment choices to address specific challenges can optimize patient care for enlarged prostate.